Skip to main content

Table 2 Lesion volumes as assessed on the [18F]FLT PET scans at the three time points: baseline, 7 days post-therapy and 28 days post-therapy

From: Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

  Baseline 7 days post-therapy 28 days post-therapy
Patients Lesion volume (mL)   
 1 46.3 31.2 22.2
 2 102.2 45.5 45.4
 3 68.3 45.7 68.4
 4 126.8 48.9 35.2
 5 72.3 32.9 28.9
 6 50.8 20.7 19.3